Baxter International is a medical instruments & supplies business based in the US. Baxter International shares (BAX) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $18.89 – a decrease of 0.11% over the previous week. Baxter International employs 38,000 staff and has a trailing 12-month revenue of around $11 billion.
Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Trade stocks, ETFs, options, futures and bonds all in one place
$0 commissions on stocks, ETFs and equity options, with low contract fees
Deposit or transfer $10,000+ to earn a 2% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&C apply.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Baxter International stock price (NYSE: BAX)
Use our graph to track the performance of BAX stocks over time.
Is it a good time to buy Baxter International stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Baxter International price performance over time
Historical closes compared with the close of $18.84 from 2025-12-02
1 week (2025-11-26)
-0.37%
1 month (2025-11-05)
4.96%
3 months (2025-09-05)
-22.85%
6 months (2025-06-05)
-37.51%
1 year (2024-12-05)
-40.94%
2 years (2023-12-05)
-45.86%
3 years (2022-12-05)
48.4268
5 years (2020-12-04)
70.0907
Is Baxter International stock undervalued or overvalued?
Valuing Baxter International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Baxter International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Baxter International's PEG ratio
Baxter International's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 34.7307. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Baxter International's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Baxter International's EBITDA
Baxter International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.1 billion.
The EBITDA is a measure of a Baxter International's overall financial performance and is widely used to measure a its profitability.
Baxter International financials
Revenue TTM
$11 billion
Operating margin TTM
10.12%
Gross profit TTM
$4.2 billion
Return on assets TTM
2.85%
Return on equity TTM
-4.66%
Profit margin
-3.09%
Book value
$14.09
Market Capitalization
$9.6 billion
TTM: trailing 12 months
Baxter International's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Baxter International.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Baxter International's total ESG risk score
Total ESG risk: 24.49
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Baxter International's overall score of 24.49 (as at 12/31/2018) is nothing to write home about – landing it in it in the 47th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Baxter International is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Baxter International's environmental score
Environmental score: 1.01/100
Baxter International's environmental score of 1.01 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Baxter International is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Baxter International's social score
Social score: 16.22/100
Baxter International's social score of 16.22 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Baxter International is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Baxter International's governance score
Governance score: 6.28/100
Baxter International's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Baxter International is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Baxter International's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Baxter International scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Baxter International hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
Baxter International Inc was last rated for ESG on: 2019-01-01.
Total ESG score
24.49
Total ESG percentile
47.44
Environmental score
1.01
Environmental score percentile
1
Social score
16.22
Social score percentile
1
Governance score
6.28
Governance score percentile
1
Level of controversy
3
Baxter International share dividends
Dividend payout ratio: 21.58% of net profits
Recently Baxter International has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Baxter International shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Baxter International's case, that would currently equate to about $0.68 per share.
While Baxter International's payout ratio might seem low, this can signify that Baxter International is investing more in its future growth.
Baxter International's most recent dividend payout was on 1 January 2026. The latest dividend was paid out to all shareholders who bought their shares by 27 November 2025 (the "ex-dividend date").
Have Baxter International's shares ever split?
Baxter International's shares were
split on a 1841:1000 basis on 30 June 2015
. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1841 shares. This wouldn't directly have changed the overall worth of your Baxter International shares – just the quantity. However, indirectly, the new 45.7% lower share price could have impacted the market appetite for Baxter International shares which in turn could have impacted Baxter International's share price.
Baxter International share price volatility
Over the last 12 months, Baxter International's shares have ranged in value from as little as $17.3908 up to $37.2498. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Baxter International's is 0.611. This would suggest that Baxter International's shares are less volatile than average (for this exchange).
Baxter International overview
Baxter International Inc. , through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers.
Frequently asked questions
null What percentage of Baxter International is owned by insiders or institutions? Currently 0.371% of Baxter International shares are held by insiders and 102.716% by institutions.How many people work for Baxter International? Latest data suggests 38,000 work at Baxter International.When does the fiscal year end for Baxter International? Baxter International's fiscal year ends in December.Where is Baxter International based? Baxter International's address is: One Baxter Parkway, Deerfield, IL, United States, 60015What is Baxter International's ISIN number? Baxter International's international securities identification number is: US0718131099What is Baxter International's CUSIP number? Baxter International's Committee on Uniform Securities Identification Procedures number is: 071813141
Discover the best stock picking services based on expert analysis, pricing, and strategy fit. Compare top tools to find the right service for your investing style in 2025.
SoFi Invest is a zero commissions platform with both active and automated investment accounts.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
